BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31484926)

  • 21. Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.
    Zeng H; Wang J; Chen T; Zhang K; Chen J; Wang L; Li H; Tuluhong D; Li J; Wang S
    Cancer Sci; 2019 Jan; 110(1):289-302. PubMed ID: 30443959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast.
    McMullen ER; Gonzalez ME; Skala SL; Tran M; Thomas D; Djomehri SI; Burman B; Kidwell KM; Kleer CG
    Breast Cancer Res Treat; 2018 Dec; 172(3):577-586. PubMed ID: 30220054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.
    Zhang Z; Zhang S; Ma P; Jing Y; Peng H; Gao WQ; Zhuang G
    Carcinogenesis; 2015 Sep; 36(9):937-45. PubMed ID: 26071398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
    Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
    Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells.
    Copley MR; Babovic S; Benz C; Knapp DJ; Beer PA; Kent DG; Wohrer S; Treloar DQ; Day C; Rowe K; Mader H; Kuchenbauer F; Humphries RK; Eaves CJ
    Nat Cell Biol; 2013 Aug; 15(8):916-25. PubMed ID: 23811688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
    Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
    Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness.
    Cocchi S; Greco V; Sidarovich V; Vigna J; Broso F; Corallo D; Zasso J; Re A; Rosatti EF; Longhi S; Defant A; Ladu F; Sanna V; Adami V; D'Agostino VG; Sturlese M; Sechi M; Aveic S; Mancini I; Sighel D; Quattrone A
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lin28 promotes transformation and is associated with advanced human malignancies.
    Viswanathan SR; Powers JT; Einhorn W; Hoshida Y; Ng TL; Toffanin S; O'Sullivan M; Lu J; Phillips LA; Lockhart VL; Shah SP; Tanwar PS; Mermel CH; Beroukhim R; Azam M; Teixeira J; Meyerson M; Hughes TP; Llovet JM; Radich J; Mullighan CG; Golub TR; Sorensen PH; Daley GQ
    Nat Genet; 2009 Jul; 41(7):843-8. PubMed ID: 19483683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma.
    Manier S; Powers JT; Sacco A; Glavey SV; Huynh D; Reagan MR; Salem KZ; Moschetta M; Shi J; Mishima Y; Roche-Lestienne C; Leleu X; Roccaro AM; Daley GQ; Ghobrial IM
    Leukemia; 2017 Apr; 31(4):853-860. PubMed ID: 27773931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lin28 is induced in primed embryonic stem cells and regulates let-7-independent events.
    Parisi S; Passaro F; Russo L; Musto A; Navarra A; Romano S; Petrosino G; Russo T
    FASEB J; 2017 Mar; 31(3):1046-1058. PubMed ID: 27920151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer.
    Li Y; Francia G; Zhang JY
    Oncotarget; 2015 Oct; 6(32):32656-68. PubMed ID: 26416451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in
    Chen CC; You JY; Lung J; Huang CE; Chen YY; Leu YW; Ho HY; Li CP; Lu CH; Lee KD; Hsu CC; Gau JP
    Haematologica; 2017 Mar; 102(3):509-518. PubMed ID: 28057739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer.
    Mansoori B; Mohammadi A; Naghizadeh S; Gjerstorff M; Shanehbandi D; Shirjang S; Najafi S; Holmskov U; Khaze V; Duijf PHG; Baradaran B
    J Cell Physiol; 2020 Feb; 235(2):920-931. PubMed ID: 31241772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.
    Yang K; Guo W; Ren T; Huang Y; Han Y; Zhang H; Zhang J
    J Exp Clin Cancer Res; 2019 May; 38(1):185. PubMed ID: 31053152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer.
    Wang T; Wang G; Hao D; Liu X; Wang D; Ning N; Li X
    Mol Cancer; 2015 Jun; 14():125. PubMed ID: 26123544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential.
    Welch JD; Baran-Gale J; Perou CM; Sethupathy P; Prins JF
    BMC Genomics; 2015 Feb; 16(1):113. PubMed ID: 25765044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-203 enhances let-7 biogenesis by targeting LIN28B to suppress tumor growth in lung cancer.
    Zhou Y; Liang H; Liao Z; Wang Y; Hu X; Chen X; Xu L; Hu Z
    Sci Rep; 2017 Feb; 7():42680. PubMed ID: 28218277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
    Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
    Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
    Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
    Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.